Bausch+Lomb UK eye drop recall

Article

Minims Eye Drops Solution has been recalled in the UK only, reveals the latest statement from Bausch+Lomb.

Minims Eye Drops Solution has been recalled in the UK only, reveals the latest statement from Bausch+Lomb.

The recall on over 36,000 bottles of proxymetacaine 0.5% refers to batch #F50052 with an expiry date July 2014. It was initiated on 10 December 2012 and does not include the USA or Asia Pacific region.

Although there have been no reports of adverse events caused by the eye drops, Bausch+Lomb advise customers not to use them for safety reasons.

Alison Bunce, pharmaceutical assessor, Defective Medicines Report Centre, commented, "We chose to initiate this recall after confirming a report of the presence of foreign particles in product from this single lot. No adverse events have been reported which have been attributed to the defective product in this single lot. No other lots have been affected. No other products in the Minims range or other B+L products are affected by this action. We are working closely with the MHRA to provide updated information regarding this recall action."

For further details please call +44 208 781 2991

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
EURETINA 2025: Boris Stanzel, MD, methotrexate is rocking the European retina landscape
Jeremiah Tao, MD, FACS, discusses his Egyptian Ophthalmological Society keynote, which focused on risk management and avoiding surgical complications in oculofacial surgery
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
© 2025 MJH Life Sciences

All rights reserved.